We demonstrated that several siRNA oligonucleotides targeting Ehtm2/EHMT2 significantly decreased the transcript and protein expression levels of Ehmt2/EHMT2 in both mouse Snord116 deletion primary cortical neurons and human PWS iPSC lines. This evidence concerns the gene EHMT2 and Prader-Willi syndrome.